Status:
RECRUITING
Social Risk Factors and Discrimination in Cancer Survivorship
Lead Sponsor:
Medstar Health Research Institute
Collaborating Sponsors:
George Washington University
Howard University
Conditions:
Social Determinants of Health
Breast Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of the proposed study is to scale social risk factor screening and referral for cancer survivors and to solidify information exchange between clinical and community settings in order to ...
Detailed Description
Despite improvements in cancer outcomes over time, significant disparities remain between Black and White cancer survivors. It is estimated that clinical care, including access to care and quality of ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosis of stage I-III breast or prostate cancer and completed curative treatment (surgery, radiation, chemotherapy) or finalized treatment plan (e.g. watch and wait); OR Stage IV breast or prostate cancer approximately 6 months from diagnosis
- Black or African American race
Exclusion
Key Trial Info
Start Date :
May 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
1116 Patients enrolled
Trial Details
Trial ID
NCT05301114
Start Date
May 5 2022
End Date
September 30 2026
Last Update
May 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MedStar Washington Hospital Center
Washington D.C., District of Columbia, United States, 20010